ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,287.10
0.30%
Dow Jones
44,296.51
0.97%
Gold vs US Dollar
2,670.985
-1.63%
Brent Oil
74.03
-0.99%
Bitcoin
98,302.00
0.26%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Horizon Therapeutics Public Limited Company (HZNP)

  7. Horizon Therapeutics Public Limited Company (HZNP) News

Horizon Therapeutics Pub... (HZNP)

Horizon Therapeutics Public Limited Company
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HZNP
DateTimeSourceHeadlineSymbolCompany
16/10/202320:44Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:HZNPHorizon Therapeutics Public Limited Company
09/10/202311:33IH Market NewsMonday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers, Disney, Lockheed Martin, and moreNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202321:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202321:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202321:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202320:30Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202320:28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202320:26Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202320:24Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202320:22Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202320:20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202320:18Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202320:16Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202320:13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202320:11Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202320:08Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202320:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202312:30Business WireRule 17(e) Announcement - Horizon Therapeutics plcNASDAQ:HZNPHorizon Therapeutics Public Limited Company
05/10/202311:40Business WireRule 17(d) Announcement – Horizon Therapeutics plcNASDAQ:HZNPHorizon Therapeutics Public Limited Company
05/10/202311:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HZNPHorizon Therapeutics Public Limited Company
03/10/202315:15Business WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
03/10/202315:06Business WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
02/10/202315:39Business WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
02/10/202315:24Business WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
02/10/202312:00Business WireHorizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023NASDAQ:HZNPHorizon Therapeutics Public Limited Company
 Showing the most relevant articles for your search:NASDAQ:HZNP

Your Recent History

LSE
GWMO
Great Western Mining
LSE
SCLP
Scancell
LSE
VAST
Vast Resources
LSE
ZED
Zenova
LSE
ITV
Itv
LSE
ECR
Ecr Minerals
LSE
CPX
Cap-xx
LSE
GDR
Genedrive
LSE
ITM
Itm Power
LSE
BGO
Bango
LSE
AAZ
Anglo Asian Mining
LSE
BOO
Boohoo
LSE
MTRO
Metro Bank
LSE
POS
Plexus
LSE
BARC
Barclays
LSE
TERN
Tern
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%

    *Across 3 years £2132.64 only £853.06